Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3073022 | 1.00 | SMPD1 (0.43) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL4260580 | 1.00 | SMPD1 (0.43) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL641208 | 0.97 | FDPS (0.41) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL504337 | 0.90 | FDPS (0.39) | SMPD1FDPSTSHRTHRBOPRM1 | |
| Ammonia Solution, Strong SCHEMBL28391001 | 0.87 | FDPS (0.38) | SMPD1FDPSTSHROPRM1 | |
| SCHEMBL6568281 | 0.81 | SMPD1 (0.45) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL3676595 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL9422192 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL123833 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL3677155 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077631-B2 | Bulk polymerisation of polyoxazolidone | BASF SE (DE) | 2024-09-03 | — | — | US | disclosed |
| EP-3824012-B1 | BULK POLYMERISATION OF POLYOXAZOLIDONE | BASF SE (DE) | 2022-09-07 | — | — | EP | disclosed |
| US-11180603-B2 | Polyoxazolidones and production thereof | BASF SE (DE) | 2021-11-23 | — | — | US | disclosed |
| US-20210253782-A1 | BULK POLYMERISATION OF POLYOXAZOLIDONE | BASF SE (DE) | 2021-08-19 | — | — | US | disclosed |
| EP-3824012-A1 | BULK POLYMERISATION OF POLYOXAZOLIDONE | BASF SE (DE) | 2021-05-26 | — | — | EP | disclosed |
| WO-2020016276-A1 | BULK POLYMERISATION OF POLYOXAZOLIDONE | BASF SE (DE) | 2020-01-23 | — | — | WO | disclosed |
| US-9493491-B2 | Method of separating acids from chemical reaction mixtures by means of apolar amines | BASF SE (DE) | 2016-11-15 | — | — | US | disclosed |
| US-20160251384-A1 | METHOD OF SEPARATING ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF APOLAR AMINES | BASF SE (DE) | 2016-09-01 | — | — | US | disclosed |
| US-9359269-B2 | Method of separating acids from chemical reaction mixtures by means of apolar amines | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-20150057388-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2015-02-26 | — | — | US | disclosed |
| US-20090020112-A1 | METHOD FOR BREAKING DOWN CELLULOSE | BASF SE (DE) | 2009-01-22 | — | — | US | disclosed |
| US-20080287684-A1 | Method for Producing Ionic Liquids | BASF SE (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080287709-A1 | Method of Separating Acids from Chemical Reaction Mixtures by Means of Apolar Amines | BASF SE (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080190321-A1 | Cellulose Solutions in Ionic Liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080164440-A1 | Solubility of Cellulose in Ionic Liquids With Addition of Amino Bases | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
| US-20070269309-A1 | Method for Operating a Liquid Ring Compressor | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-22 | — | — | US | disclosed |
| US-20070095645-A1 | Distillation of ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-03 | — | — | US | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287684-A1 | Method for Producing Ionic Liquids | HACL2, HAO2, SLC6A12 | SMPD1 3796/4885FDPS 3994/4885TSHR 1407/4885 |
| US-20160251384-A1 | METHOD OF SEPARATING ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF APOLAR AMINES | APOB, ADAR, LIPA | SMPD1 719/4885FDPS 2042/4885TSHR 917/4885 |
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | SMPD1 297/4885FDPS 1434/4885TSHR 1936/4885 |
| US-20080287709-A1 | Method of Separating Acids from Chemical Reaction Mixtures by Means of Apolar Amines | APOB, ADAR, LIPA | SMPD1 719/4885FDPS 2042/4885TSHR 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.